This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Kermit Crawford, Walgreens President Of Pharmacy, Health And Wellness, Is Retiring After 31 Years With The Company. (Photo: Business Wire)

Walgreen Co. (NYSE: WAG) (Nasdaq: WAG) today announced that Kermit Crawford, president of Pharmacy, Health and Wellness, has decided to retire after 31 years in a variety of advancing roles with the company to take on new opportunities, including continuing to serve as a senior counselor to Walgreens President and Chief Executive Officer Greg Wasson. Crawford announced that he plans to join the University of Southern California’s School of Pharmacy, where will serve as Executive in Residence and Senior Advisor to the Dean. Crawford currently is a member of the USC School of Pharmacy’s board of councilors. He also will serve as National Chair for the American Diabetes Association’s new Ad Council campaign across the country. The association recently named him volunteer of the year in his longtime role as a member of the organization’s board for the Northern Illinois and Indiana region. His retirement from Walgreens will be effective Dec. 31, 2014, after which he will assume the role of senior counselor.
Kermit Crawford, Walgreens President of Pharmacy, Health and Wellness, is retiring after 31 years wi ...

Kermit Crawford, Walgreens President of Pharmacy, Health and Wellness, is retiring after 31 years with the company. (Photo: Business Wire)

“After 31 years with Walgreens, starting as a pharmacy intern in my 20s, the time is right to retire from the company to broaden my horizons and seek new ways to serve,” Crawford said. “I love Walgreens, cherish my years and friends here and the incredibly dedicated people across the company. To me, community pharmacy has long been an unsung hero in our health care system, helping primary caregivers to provide convenient, affordable and essential health and wellness services in neighborhoods across America. I look forward to continuing to help Greg Wasson and the team to advance the role of community pharmacy in health care as I also pursue other opportunities to provide leadership in new areas.”

1 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,798.49 -14.90 -0.08%
S&P 500 2,090.11 +1.24 0.06%
NASDAQ 5,127.5250 +11.3820 0.22%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs